Polar Capital LLP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
Polar Capital LLP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,482,000
-5.6%
75,0000.0%0.02%
-8.3%
Q1 2019$2,628,000
-30.4%
75,0000.0%0.02%
-25.0%
Q3 2018$3,776,000
-74.8%
75,000
-70.0%
0.03%
-64.4%
Q2 2018$14,963,000
+18.8%
250,000
-9.1%
0.09%
-29.1%
Q1 2018$12,595,000
+58.0%
275,000
+37.5%
0.13%
+54.9%
Q4 2017$7,970,000
-41.2%
200,000
-41.0%
0.08%
-46.4%
Q3 2017$13,558,000
+162.1%
338,956
+182.5%
0.15%
+118.6%
Q2 2017$5,172,000
-68.5%
120,000
-77.1%
0.07%
-71.5%
Q1 2017$16,433,000
+319.9%
525,000
+238.7%
0.25%
+296.8%
Q4 2016$3,914,000
+104.2%
155,000
+100.0%
0.06%
+87.9%
Q3 2016$1,917,000
-14.8%
77,500
-29.9%
0.03%
-21.4%
Q2 2016$2,251,000
+20.9%
110,525
-9.5%
0.04%
+20.0%
Q1 2016$1,862,000
+30.7%
122,086
+15.2%
0.04%
+34.6%
Q4 2015$1,425,000
-34.5%
106,021
-31.6%
0.03%
-40.9%
Q3 2015$2,174,000
-9.2%
154,943
+9.8%
0.04%
-4.3%
Q2 2015$2,395,000
+77.4%
141,074
+26.3%
0.05%
+76.9%
Q1 2015$1,350,000
+401.9%
111,673
+244.4%
0.03%
+420.0%
Q4 2014$269,00032,4280.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders